COMMUNIQUÉS West-GlobeNewswire

Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
16/09/2026
Collaboration with leading 22-location interventional pain practice supports Milestone’s longer-term reimbursement strategy ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: [...]
NeuroSigma Expands Payment Options for the Monarch eTNS® System
16/09/2026
Families prescribed Monarch can now pay with digital wallets or third-party installment plans at checkout LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced expanded payment options for [...]
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
16/09/2026
Total national coverage footprint for PENFS increases to over 120 million covered lives CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical [...]
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
16/09/2026
HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (NYSE: IBO) (the “ Company ” or “ Impact ”) announced that a Form F-4 registration statement (the “ Registration Statement ”) was filed with the U.S. [...]
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
16/09/2026
MINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc. ("PetVivo"), in cooperation with its parent, PetVivo Holdings, Inc. (OTCQX: PETV), and its other subsidiaries, Somatrix Technologies, Inc. and [...]
NEXGEL Announces Date for Investor Update Call
16/09/2026
LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians [...]
X-Chem Named First Winner of Chordoma Foundation TBXT Challenge with Discovery of Novel Binder for Untreatable Bone Cancer Target
16/09/2026
Groundbreaking synergy of DEL screening and computational chemistry yields the first compound to meet the TBXT Challenge’s submicromolar binding threshold for brachyury (TBXT) WALTHAM, Mass., Sept. 16, 2026 (GLOBE [...]
Dr. Peter Goldman Returns to the Bay Area, Bringing Zone Technique and a Distinct Approach to Healing to Berkeley, CA
16/09/2026
Founder of Zone School of Healing Uses the Zone Technique to Balance the Body’s Six Main Systems, Helping Clients Pursue Healing at the Highest Level BERKELEY, CA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- After nearly a [...]
TerrAscend Strengthens Leadership Position in New Jersey with Closing of Aunt Mary’s Transaction
16/09/2026
Expands New Jersey retail footprint to five dispensaries Dispensary generates over US$10 million in annualized revenue and will be immediately accretive to EBITDA and cash flow TORONTO, Sept. 16, 2026 (GLOBE NEWSWIRE [...]
Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial
16/09/2026
LONDON and PHILADELPHIA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, announces today that it has achieved clinical proof of [...]
Horse Peak Gelatin Launch 2026: Natural Vitality Formula For Men Read HorsePeak Gummies Supplement Facts & Ingredients Highlights
16/09/2026
Discover Horse Peak Gelatin Gummies 2026 and explore the natural vitality formula, supplement facts, key ingredients, potential benefits, serving details, and everything you should know before choosing this men's [...]
NADP Foundation Issues Request for Proposals
16/09/2026
DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) Foundation is pleased to issue its 2027 request for proposal (RFP) with the objective of supporting innovative projects that [...]
Ignitus Recovery Announces Acquisition of AIM Health: Building on a 20-Year Legacy
16/09/2026
BOULDER, Colo., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Ignitus Recovery is proud to announce the acquisition of AIM Health Boulder, a respected behavioral health program serving young adults, individuals, and families in [...]
Kailera Therapeutics to Participate in September Investor Conferences
16/09/2026
WALTHAM, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/09/2026
WATERTOWN, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases [...]
AAVantgarde to Showcase Clinical Progress in Usher 1B and Stargardt Disease at EURetina 2026
16/09/2026
MILAN, Sept. 16, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), the clinical-stage biotechnology company developing genetic medicines for inherited retinal diseases (IRDs) using its proprietary dual-AAV [...]
Shock Top and Spirit Halloween Brew Up a Scary Good Collaboration
16/09/2026
Limited-Edition Candy Corn Wheat Ale Craft Beer and Spirit Halloween-Exclusive Wedgehead Costume Bring Big Flavor, Big Fun, and Head-Turning Halloween Energy to Fans Nationwide PORTLAND, Ore., Sept. 16, 2026 (GLOBE [...]
NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference
16/09/2026
CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating [...]
Sironax Announces Option Exercise and Asset Purchase
16/09/2026
Novartis exercises option to acquire Sironax’s brain delivery platform Sironax to advance three clinical-stage programs and multiple early-stage candidates using purchase proceeds Sironax to retain development rights to [...]

Pages